HAE · Insider Trading
Haemonetics Corporation
Every open-market purchase and sale reported by HAE officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-03 | Roy Galvin | EVP, Chief Commercial Officer | F | −146 | −$17.47K |
| 2026-07-28 | Ellen M Zane | Director | A | +2,538 | — |
| 2026-07-28 | Lloyd Emerson Johnson | Director | A | +2,538 | — |
| 2026-07-28 | Martin D Madaus | Director | A | +2,538 | — |
| 2026-07-28 | Diane M Bryant | Director | A | +2,538 | — |
| 2026-07-28 | Robert E Abernathy | Director | A | +2,538 | — |
| 2026-07-28 | Michael J Coyle | Director | A | +2,538 | — |
| 2026-07-28 | Mark W Kroll | Director | A | +2,538 | — |
| 2026-07-28 | Claire Pomeroy | Director | A | +2,538 | — |
| 2026-06-08 | Farris Maryanne Maunsell | VP, Chief Accounting Officer | F | −259 | −$18.46K |
| 2026-06-08 | Laurie A. Miller | SVP, Human Resources | F | −313 | −$22.31K |
| 2026-05-19 | Christopher Simon | President & CEO | MIXED | +68,663 | −$544.94K |
| 2026-05-19 | Laurie A. Miller | SVP, Human Resources | MIXED | +12,375 | −$53.36K |
| 2026-05-19 | Roy Galvin | EVP, Chief Commercial Officer | MIXED | +26,656 | −$49.48K |
| 2026-05-19 | Farris Maryanne Maunsell | VP, Chief Accounting Officer | MIXED | +2,023 | −$11.09K |
| 2026-05-19 | James DArecca | EVP, Chief Financial Officer | MIXED | +26,807 | −$141.01K |
| 2026-05-19 | Frank Chan | EVP, Chief Operating Officer | MIXED | +26,989 | −$30.73K |
| 2026-05-19 | Michelle L Basil | EVP and General Counsel | MIXED | +25,511 | −$163.97K |
| 2026-05-05 | James DArecca | EVP, Chief Financial Officer | F | −655 | −$38.82K |
| 2025-11-12 | Mark W Kroll | Director | Buy | +1,400 | +$98.78K |
| 2025-11-03 | Roy Galvin | EVP, Chief Commercial Officer | F | −145 | −$7.25K |
| 2025-09-24 | Laurie A. Miller | SVP, Human Resources | F | −238 | −$11.89K |
| 2025-07-25 | Robert E Abernathy | Director | A | +2,693 | — |
| 2025-07-25 | Diane M Bryant | Director | A | +2,693 | — |
| 2025-07-25 | Michael J Coyle | Director | A | +2,693 | — |
| 2025-07-25 | Charles J Dockendorff | Director | A | +2,693 | — |
| 2025-07-25 | Lloyd Emerson Johnson | Director | A | +2,693 | — |
| 2025-07-25 | Mark W Kroll | Director | A | +2,693 | — |
| 2025-07-25 | Claire Pomeroy | Director | A | +2,693 | — |
| 2025-07-25 | Ellen M Zane | Director | A | +2,693 | — |
| 2025-06-13 | Michelle L Basil | EVP and General Counsel | A | +6,755 | — |
| 2025-06-13 | Roy Galvin | EVP, Chief Commercial Officer | A | +5,689 | — |
| 2025-06-09 | Farris Maryanne Maunsell | VP, Chief Accounting Officer | A | +2,662 | — |
| 2025-06-09 | Laurie A. Miller | SVP, Human Resources | A | +3,195 | — |
| 2025-06-03 | Michelle L Basil | EVP and General Counsel | MIXED | +8,085 | −$518.20K |
| 2025-06-03 | James DArecca | EVP, Chief Financial Officer | MIXED | +6,357 | −$406.84K |
| 2025-06-03 | Laurie A. Miller | SVP, Human Resources | MIXED | +5,494 | −$158.39K |
| 2025-06-03 | Christopher Simon | President & CEO | MIXED | +40,432 | −$1.82M |
| 2025-05-20 | Christopher Simon | President & CEO | A | +21,405 | — |
| 2025-05-20 | James DArecca | EVP, Chief Financial Officer | A | +7,111 | — |
| 2025-05-20 | Michelle L Basil | EVP and General Counsel | A | +5,689 | — |
| 2025-05-20 | Roy Galvin | President, Global Plasma & BC | A | +6,755 | — |
| 2025-05-20 | Frank Chan | EVP, Chief Operating Officer | A | +5,689 | — |
| 2025-05-20 | Laurie A. Miller | SVP, Human Resources | A | +3,200 | — |
| 2025-05-20 | Farris Maryanne Maunsell | VP, Chief Accounting Officer | A | +800 | — |
| 2025-05-19 | Christopher Simon | President & CEO | F | −9,480 | −$664.32K |
| 2025-05-19 | Laurie A. Miller | SVP, Human Resources | F | −683 | −$47.83K |
| 2025-05-19 | Roy Galvin | President, Global Plasma & BC | F | −458 | −$32.02K |
| 2025-05-19 | Farris Maryanne Maunsell | VP, Chief Accounting Officer | F | −128 | −$8.94K |
| 2025-05-19 | James DArecca | EVP, Chief Financial Officer | F | −1,868 | −$130.76K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Christopher Simon | President & CEO | 366,360 | $43.63M |
| Michelle L Basil | EVP and General Counsel | 68,829 | $8.20M |
| James DArecca | EVP, Chief Financial Officer | 54,444 | $6.48M |
| Laurie A. Miller | SVP, Human Resources | 40,987 | $4.88M |
| Roy Galvin | EVP, Chief Commercial Officer | 39,805 | $4.74M |
| Robert E Abernathy | Director | 27,519 | $3.28M |
| Mark W Kroll | Director | 27,295 | $3.25M |
| Charles J Dockendorff | Director | 25,041 | $2.98M |
| Ellen M Zane | Director | 21,911 | $2.61M |
| Claire Pomeroy | Director | 19,410 | $2.31M |
| Michael J Coyle | Director | 17,932 | $2.14M |
| Lloyd Emerson Johnson | Director | 15,471 | $1.84M |
| Diane M Bryant | Director | 9,664 | $1.15M |
| Farris Maryanne Maunsell | VP, Chief Accounting Officer | 6,242 | $743.36K |
| Frank Chan | EVP, Chief Operating Officer | 5,401 | $643.21K |
| Martin D Madaus | Director | 2,538 | $302.25K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the HAE quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.